Skip to main content
. Author manuscript; available in PMC: 2024 Oct 28.
Published in final edited form as: AIDS. 2017 Mar 27;31(6):745–752. doi: 10.1097/QAD.0000000000001389

Fig. 3. Longitudinal pharmacokinetic assessment of plasma TFV concentrations in cycling macaques.

Fig. 3.

STI, sexually transmitted infection; TFV, tenofovir. (a) TFV concentrations in plasma of STI negative (closed circles) and STI positive (open squares) 30 min after vaginal administration of 1% TFV gel. (b) Plasma TFV concentrations in STI-negative (closed circles) and STI-positive (open squares) animals stratified by the luteal and follicular phase of the menstrual cycle. Solid black line indicates the median.